Brent A Hanks

19PUBLICATIONS
51CO-AUTHORS
Tumour immunologyInnate immunityChemical and thermal processes in energy and combustionMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 23, 2026
Tumor-derived Extracellular Vesicles Induce ER Stress to Drive Tolerogenic Dendritic Cell Development in the Tumor Microenvironment.

Xueying Wang, Michael P Plebanek, Y-Van Nguyen

|Nov 24, 2025
Tumor NLRP3 Amplification Promotes Immunotherapy Resistance by Suppressing MHC Class I Expression.

Bala Theivanthiran, Nagendra Yarla, Kaylee Villareal

|Aug 01, 2025
Unlocking the Therapeutic Potential of the cGAS-STING Pathway through TREX1 Targeting.

Brent A Hanks

|Jul 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors.

Mohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra

|Feb 19, 2025
GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling.

Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant

|May 10, 2024
A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression.

Michael P Plebanek, Yue Xue, Y-Van Nguyen

Pageof 4

Frequent Collaborators

5 joint publications

Georgia M Beasley

5 joint publications

Nicholas C DeVito

4 joint publications

Alisha Holtzhausen

3 joint publications

Balamayooran Theivanthiran